Megestrol Acetate NDC 60687-916

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-916Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0916Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-916-08	60687091608	3 TRAY in 1 CASE (60687-916-08) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-916-48) / 10 mL in 1 CUP, UNIT-DOSE (60687-916-42)Marketed from Jan 5, 2026
60687-916-56	60687091656	10 TRAY in 1 CASE (60687-916-56) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-916-48) / 10 mL in 1 CUP, UNIT-DOSE (60687-916-42)Marketed from Jan 5, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Megestrol Acetate
Generic name (nonproprietary): megestrol acetate
Active ingredients: Megestrol acetate — 40 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077404
Marketing start: Jan 5, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 60687-916_47a6376f-18d0-c130-e063-6394a90a918dSPL ID 47a6376f-18d0-c130-e063-6394a90a918dSPL set ID 2921731a-6866-4dc8-8f6b-b636abf7bcf8RxCUI 860225UNII TJ2M0FR8ES
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687091608 followed by a unit qualifier and the quantity

Package 60687-0916-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 5, 2026.

Indications (excerpt from the label)

INDICATIONS & USAGE Megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077404

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077404
Product	Strength	Form · route	Labeler	Product NDC
Megestrol Acetate	Megestrol acetate 40 mg/mL	SuspensionOral	ANI Pharmaceuticals, Inc.	70954-896
Megestrol Acetate	Megestrol acetate 400 mg/10mL	SuspensionOral	Major Pharmaceuticals	0904-7577
Megestrol Acetate	Megestrol acetate 400 mg/10mL	SuspensionOral	PAI Holdings, LLC dba PAI Pharma	0121-1038